IGM Biosciences, Inc. (NASDAQ:IGMS) Q4 2022 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the IGM Biosciences' Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. Today's call is being recorded.
Igm Biosciences Inc. (IGMS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 3,334,355 | $45,814,038 | 1.98% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,156,656 | $43,372,453 | +1% | 0.23% |
| 3. | Alkeon Capital Management Panayotis Takis Sparaggis | 711,777 | $9,779,816 | -15% | 0.02% |
| 4. | D E Shaw D. E. Shaw | 324,537 | $4,459,139 | -17% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 220,319 | $3,027,183 | -24% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.14 | 60,000 | Director | 218,200 | 2022-11-08 | Filing | |
| $19.62 | 5,821 | Director | 35,305 | 2022-09-29 | Filing | |
| $20.97 | 6,172 | Director | 29,484 | 2022-09-28 | Filing | |
| $19.99 | 507 | Director | 23,312 | 2022-09-27 | Filing | |
| $16.00 | 1,481 | Large Shareholder, Director | 73,462 | 2022-05-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.01 | 15 | Officer | 54,742 | 2023-05-23 | Filing | |
| $12.30 | 1,244 | Officer | 54,757 | 2023-05-23 | Filing | |
| $13.01 | 15 | Officer | 50,711 | 2023-05-23 | Filing | |
| $12.30 | 1,244 | Officer | 50,726 | 2023-05-23 | Filing | |
| $13.01 | 15 | Officer, Director | 121,761 | 2023-05-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 845,591 | $11,618,420 | 0% | |
| 2. | 770,596 | $10,587,989 | 0% | |
| 3. | 580,362 | $7,974,174 | 0% | |
| 4. | 485,027 | $6,664,271 | 0% | |
| 5. | 393,514 | $5,406,882 | 0% |
News See All
Hedge Fund and Insider Trading News: Ken Griffin, Crispin Odey, Irenic Capital Management, Balyasny Asset Management, Oaktree Capital Management, Elliott Management, Coinbase Global Inc (Coinbase), Tricida, Inc. (TCDA), and More
The Bank of England’s dramatic intervention to control bond yields earlier this week threatens the central bank’s fight to contain inflation and prevent a decline in pound, according to hedge fund...
Top 5 Biotech Stocks to Buy According to Jeremy Green's Redmile Group
In this article, we discuss the top 5 biotech stocks to buy according to Jeremy Green's Redmile Group.
Were Hedge Funds Right About Piling Into IGM Biosciences, Inc. (IGMS)?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database.
Is IGMS A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Fund and Insider Trading News: Kyle Bass, Alan Howard, Louis Bacon, IGM Biosciences Inc (IGMS), Seacor Holdings, Inc. (CKH), and More
Kyle Bass, Hayman Capital Management chief investment officer, joined “Squawk Box” on Wednesday to discuss what he thinks may be the biggest issues President-elect Joe Biden when it comes to U.S.-...
Hedge Funds Getting Bullish On IGM Biosciences, Inc. (IGMS)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Was The Smart Money Right About IGM Biosciences, Inc. (IGMS)?
We hate to say this but, we told you so.
Hedge Funds Have Never Been This Bullish On IGM Biosciences, Inc. (IGMS)
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade...
Billionaire Hedge Funds
